How a bootstrap discovery campaign validated clinical workflows, conquered pre-pandemic friction, and secured early adoption leading to a successful asset acquisition.
Telelytics is a remote care platform. Before the pandemic, the medical community viewed remote care with heavy skepticism. The prevailing sentiment among doctors was: "We cannot practice medicine properly if it is remote."
To make things more challenging, Telelytics was a 2 person seed-stage startup. At this stage, Telelytics had no funding, no salary, no budget, limited marketing and sales enablement, and little runway for R&D.
Doctors themselves argued "we dont use video visit technology. Our practice requires the patient to be in the office, not over video."
Furthermore, cold calls went unanswered since the doctor was usually with a patient or not available.
Since cold calling failed, I pivoted strategy and decided to drive in person to medical offices, physically knocked on doors, bought the office lunch, and learned what enablement collateral could help the deal.
Angel helped seed stage startup Telelytics feasibility test the Bay Area medical practice market. This provided valuable product feedback, helpful for our investor's acquisition of the technology.
